{"created":"2024-11-15T08:20:02.894195+00:00","id":2000208,"links":{},"metadata":{"_buckets":{"deposit":"859376f2-b1db-4970-8ff2-930a9cd127e6"},"_deposit":{"created_by":8,"id":"2000208","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"2000208"},"status":"published"},"_oai":{"id":"oai:fmu.repo.nii.ac.jp:02000208","sets":["1731487166818:1731487329839:1731487664323"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3121-3p","subitem_title_language":"en"}]},"item_1617186385884":{"attribute_name":"Alternative Title","attribute_value_mlt":[{"subitem_alternative_title":"BCR/ABLチロシンキナーゼインヒビターであるニロチニブは、miR-3121-3pの発現減弱を介して血管内皮細胞でのIL-1βの発現を亢進する","subitem_alternative_title_language":"ja"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorAlternatives":[{"creatorAlternative":"Sukegawa, Masumi","creatorAlternativeLang":"en"}],"creatorNames":[{"creatorName":"助川, 真純","creatorNameLang":"ja"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617187087799":{"attribute_name":"Dissertation Number","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第598号"}]},"item_1617187112279":{"attribute_name":"Degree Name","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"ja"}]},"item_1617187136212":{"attribute_name":"Date Granted","attribute_value_mlt":[{"subitem_dategranted":"2017-09-27"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1016/j.leukres.2017.05.005","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2019-01-30"}],"displaytype":"detail","filename":"Thesis_K598_review.pdf","format":"application/pdf","mimetype":"application/pdf","url":{"label":"内容・審査結果要旨","objectType":"abstract","url":"https://fmu.repo.nii.ac.jp/record/2000208/files/Thesis_K598_review.pdf"},"version_id":"91c3bd57-92db-4a90-aabd-532ced1b5a1a"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2020-08-19"}],"displaytype":"detail","filename":"Thesis_K598_fulltext.pdf","format":"application/pdf","license_note":"© 2017. This accepted manuscript version is made available under the CC-BY-NC-ND 4.0 license. Published version: Leuk Res. 2017 Jul;58:83-90. doi: 10.1016/j.leukres.2017.05.005","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://fmu.repo.nii.ac.jp/record/2000208/files/Thesis_K598_fulltext.pdf"},"version_id":"cd319bcd-cd36-4e39-aae2-ef368f27d052"}]},"item_1617944105607":{"attribute_name":"Degree Grantor","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"福島県立医科大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"21601","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_title":"The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3121-3p","item_type_id":"40002","owner":"8","path":["1731487664323"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-01-30"},"publish_date":"2019-01-30","publish_status":"0","recid":"2000208","relation_version_is_last":true,"title":["The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3121-3p"],"weko_creator_id":"8","weko_shared_id":-1},"updated":"2025-01-17T02:38:02.564892+00:00"}